“The EU continues to strengthen its partnership with the_African Union.Our actions speak for themselves: we provide €100M to @AfricaCDC to support vaccination campaigns. At global level EU doubling #COVAX contribution to €1 billion. We can only be safe together. #StrongerTogether” the EU top diplomat Josep Borrell wrote.
“We will only be safe if the whole world is safe. As announced in the G7, the EU is doubling its contribution to COVAX, the world’s facility for universal access to vaccines – from €500 million to €1 billion.
Deliveries will start soon. A true moment of global solidarity” Ursula von der Leyen, the European Commission president tweeted.
“We are providing €100 million in humanitarian assistance for the roll out of vaccination in Africa.
The funding will be used to strengthen health systems, ensure the cold chains, buy equipment and train staff” she continued.
Health authorities in Democratic Republic of Congo (DRC) informed that they plan to introduce a second Ebola vaccine, manufactured by Johnson & Johnson, to counter the second-worst outbreak of the deadly virus.
The team overseeing Congo’s Ebola response did not reveal when exactly the J&J vaccine would be employed. It will complement another vaccine manufactured by Merck, which has been administered to more than 225,000 people since August 2018. Unlikely fhe J&J vaccine requires two injections eight weeks apart, unlike the Merck product, which requires a single shot.
According to the Congolese authorities, they will offer J&J vaccine to Congolese traders who cross into Rwanda and then to residents of the province neighbouring the epicentre of the outbreak to “create a corridor of immunised people”.